Literature DB >> 3056257

Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins.

Y Matsumoto1, F Ikeda, T Kamimura, Y Yokota, Y Mine.   

Abstract

A highly cephem-resistant Escherichia coli strain, FP1546, isolated from the fecal flora of laboratory dogs previously administered beta-lactam antibiotics was found to produce a beta-lactamase, FEC-1, of 48-kilodalton size and pI 8.2. FEC-1 hydrolyzed cefuroxime, cefotaxime, cefmenoxime, and ceftriaxone, as well as the enzymatically less-stable antibiotics cephaloridine, cefotiam, and cefpiramide. Of the oxyimino-cephalosporins, ceftizoxime was fairly stable to FEC-1. FEC-1 differed notably from chromosomal E. coli cephalosporinase, especially in its broad-spectrum substrate profile and its high inhibition by clavulanic acid, sulbactam, and imipenem. A conjugation study revealed that FEC-1 was encoded by a 74-megadalton plasmid, pFCX1. This may be the first instance of a plasmid-mediated oxyimino-cephalosporinase from E. coli.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056257      PMCID: PMC172385          DOI: 10.1128/AAC.32.8.1243

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  Plasmid-mediated beta-lactamases of Gram-negative bacteria: properties and distribution.

Authors:  M Matthew
Journal:  J Antimicrob Chemother       Date:  1979-07       Impact factor: 5.790

2.  Spread of a "Pseudomonas-specific" beta-lactamase to plasmids of enterobacteria.

Authors:  A A Medeiros; R W Hedges; G A Jacoby
Journal:  J Bacteriol       Date:  1982-02       Impact factor: 3.490

3.  Characterization of eight beta-lactamases of Gram-negative bacteria.

Authors:  T Sawai; M Kanno; K Tsukamoto
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

4.  Purification and some properties of a cephalosporinase from Proteus vulgaris.

Authors:  N Matsubara; A Yotsuji; K Kumano; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

5.  Purification and properties of cephalosporinase in Escherichia coli.

Authors:  S Minami; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

6.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

7.  R-mediated beta-lactamases and episomal resistance to the beta-lactam drugs in different bacterial hosts.

Authors:  P M Kontomichalou; E G Papachristou; G M Levis
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

8.  Mechanism of action of the new orally active cephalosporin FK027.

Authors:  Y Shigi; Y Matsumoto; M Kaizu; Y Fujishita; H Kojo
Journal:  J Antibiot (Tokyo)       Date:  1984-07       Impact factor: 2.649

9.  Properties of novel beta-lactamase produced by Bacteroides fragilis.

Authors:  A Yotsuji; S Minami; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

10.  A plasmid-mediated cephalosporinase from Achromobacter species.

Authors:  R Levesque; P H Roy; R Letarte; J C Pechère
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

View more
  45 in total

1.  Early dissemination of CTX-M-derived enzymes in South America.

Authors:  Marcela Radice; Pablo Power; Jose Di Conza; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 2.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 3.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

4.  Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.

Authors:  Akiko Shimizu-Ibuka; Mika Oishi; Shoko Yamada; Yoshikazu Ishii; Kiyoshi Mura; Hiroshi Sakai; Hiroshi Matsuzawa
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

5.  High Diversity of CTX-M Extended-Spectrum β-Lactamases in Municipal Wastewater and Urban Wetlands.

Authors:  Timothy R Borgogna; Joanna-Lynn Borgogna; Jenna A Mielke; Celeste J Brown; Eva M Top; Ryan T Botts; David E Cummings
Journal:  Microb Drug Resist       Date:  2015-12-15       Impact factor: 3.431

Review 6.  Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

7.  Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum beta-lactamase in a neonatal unit in Sousse, Tunisia.

Authors:  Olfa Bouallègue-Godet; Youssef Ben Salem; Laëtitia Fabre; Marie Demartin; Patrick A D Grimont; Ridha Mzoughi; François-Xavier Weill
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

Review 8.  Beta-lactamase nomenclature.

Authors:  George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

9.  PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan.

Authors:  Naohiro Shibata; Hiroshi Kurokawa; Yohei Doi; Tetsuya Yagi; Kunikazu Yamane; Jun-ichi Wachino; Satowa Suzuki; Kouji Kimura; Satoshi Ishikawa; Haru Kato; Yoshiyuki Ozawa; Keigo Shibayama; Kumiko Kai; Toshifumi Konda; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

10.  CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish hospital.

Authors:  Antonio Oliver; Teresa M Coque; Diana Alonso; Aránzazu Valverde; Fernando Baquero; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.